Found 26 matching trials
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma PHASE2 RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma PHASE2 The purpose of this study is to find out what effect an antibody called Hum...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Los Angeles (Data Collection Only)
Learn More & Join Trial
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma PHASE1 RATIONALE: Biological therapies such as beta-glucan use different ways to s...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE1 This is a safety / feasibility trial evaluating the combination of a humani...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma PHASE2 A six courses regimen consisting of a 8 hour infusion (ch14.18/CHOmAb 20 mg...
Show More Location
University Hospital Graz
Learn More & Join Trial
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow PHASE2 Children and adults diagnosed with high-risk neuroblastoma patients with pr...
Show More Status
Active Not Recruiting
Location
Riley Hospital for Children
Learn More & Join Trial
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2 PHASE1 Subjects with relapsed or refractory neuroblastoma and osteosarcoma will re...
Show More Location
University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics
Learn More & Join Trial
Therapy for Children With Advanced Stage Neuroblastoma PHASE2 Neuroblastoma is the most common extracranial solid tumor in childhood, wit...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE2 RATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protei...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Learn More & Join Trial